Saturday, September 23, 2006

Drug Safety Overhaul Is Urged

Article in today's Los Angeles Times -- Drug Safety Overhaul Is Urged, by Ricardo Alonso-Zaldivar and Denise Gellene:

    The government's drug safety system is seriously out of balance, devoting too much
    attention to approving new medications and not enough follow-up to uncovering risky
    side effects, a blue-ribbon scientific panel concluded in a major report released Friday.

    Convened at the request of the Food and Drug Administration after a popular painkiller
    was linked to heart attacks, the experts in medicine, pharmacology, law and other fields
    issued a sweeping call for reform. Its 25 recommendations include establishing a fixed
    term for the FDA commissioner, restricting ubiquitous drug commercials and placing a
    special cautionary symbol on the packaging of newly approved medications.

http://lawprofessors.typepad.com/mass_tort_litigation/2006/09/drug_safety_ove.html

FDA | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef00d83460618669e2

Listed below are links to weblogs that reference Drug Safety Overhaul Is Urged:

» FDA to Track Drugs More Closely from Unsafe Drugs
The U.S. Food and Drug Administration plans to monitor side effects of medications after they are put on the market more closely. Criticism of the FDA's regulation of the drug industry has mounted since Merck & Co. withdrew its painkiller... [Read More]

Tracked on Feb 8, 2007 11:13:21 AM

Comments

Post a comment